| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5832874 | International Immunopharmacology | 2014 | 5 Pages |
Abstract
We confirmed the efficacy of T2 treatment in CD and showed that microscopic inflammation was attenuated by the modulation of in situ levels of inflammatory cytokines. The therapeutic mechanisms might involve the up-regulation of Foxp3+ Tregs.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Guanwei Li, Jianan Ren, Gefei Wang, Guosheng Gu, Dong Hu, Huajian Ren, Zhiwu Hong, Xiuwen Wu, Song Liu, Jieshou Li,